Amylyx Pharmaceuticals, Inc.
AMLX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$302 | $49 | -$198 | -$88 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $33 | $0 | $22 | $3 |
| Change in WC | -$46 | -$66 | -$2 | $5 |
| Other Non-Cash | $146 | $27 | -$2 | $5 |
| Operating Cash Flow | -$168 | $12 | -$180 | -$75 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$3 | -$0 |
| Net Acquisitions | $0 | $0 | $236 | $0 |
| Inv. Purchases | -$232 | -$301 | -$416 | -$49 |
| Inv. Sales/Matur. | $344 | $394 | $179 | $3 |
| Other Inv. Act. | -$36 | $0 | -$236 | $0 |
| Investing Cash Flow | $76 | $92 | -$239 | -$46 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $26 |
| Stock Issued | $2 | $7 | $432 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$3 | -$1 | $133 |
| Financing Cash Flow | $0 | $4 | $432 | $159 |
| Forex Effect | -$0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$92 | $108 | $13 | $37 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $171 | $63 | $50 | $13 |
| End Cash | $79 | $170 | $63 | $50 |
| Free Cash Flow | -$168 | $11 | -$182 | -$75 |